The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic stem cell transplant patients

被引：9
|
作者：
Harrington, S. M. [1 ]
Buller, R. S.
Storch, G. A.
Li, L.
Fischer, S. H.
Murray, P. R.
Gea-Banacloche, J. C.
机构：
[1] NCI, Dept Lab Med, Warren Grant Magnuson Clin Ctr, NIH, Bethesda, MD 20892 USA
[2] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA
[3] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA
来源：
BONE MARROW TRANSPLANTATION | 2007年 / 39卷 / 04期
关键词：
D O I：
10.1038/sj.bmt.1705558
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：237 / 238
页数：2
相关论文
共 50 条
  • [31] Preemptive antiviral therapy for CMV infection in allogeneic stem cell transplant recipients guided by the viral doubling time in the blood
    Solano, C.
    Gimenez, E.
    Pinana, J. L.
    Vinuesa, V.
    Poujois, S.
    Zaragoza, S.
    Calabuig, M.
    Navarro, D.
    BONE MARROW TRANSPLANTATION, 2016, 51 (05) : 718 - 721
  • [32] Earlier relapse detection after allogeneic haematopoietic stem cell transplantation by chimerism assays: Digital PCR versus quantitative real-time PCR of insertion/deletion polymorphisms
    Valero-Garcia, Jennifer
    del Carmen Gonzalez-Espinosa, Maria
    Barrios, Manuel
    Carmona-Antonanzas, Greta
    Garcia-Planells, Javier
    Ruiz-Lafora, Carlos
    Fuentes-Galvez, Ainhoa
    Jimenez-Velasco, Antonio
    PLOS ONE, 2019, 14 (02):
  • [33] Real-time PCR SNP assay for monitoring chimerism after allogeneic stem cell transplantation.
    Naparstek, E
    Vainas, O
    Eshel, R
    BLOOD, 2003, 102 (11) : 433B - 433B
  • [34] Determining the appropriate PCR trigger for pre-emptive Anti-CMV therapy in allogeneic stem cell transplant recipients.
    Mohite, Unmesh
    Westmoreland, Diana
    O'Callaghan, Una
    Burnett, Alan K.
    Wilson, Keith M. O.
    BLOOD, 2006, 108 (11) : 412B - 412B
  • [35] PCR-based preemptive therapy for CMV reactivation in allogeneic stem cell transplant recipients with cidofovir: a preliminary single center experience
    Bosi, A
    Laszlo, D
    Paci, C
    Bartolozzi, B
    Guidi, S
    Ciolli, S
    Saccardi, R
    Vannucchi, AM
    Ferrini, PR
    BONE MARROW TRANSPLANTATION, 2001, 27 : S52 - S53
  • [36] Cytomegalovirus antigen (CMV AG) screening to direct therapy for pediatric allogeneic stem cell transplant(alloSCT) patients at risk for CMV infection.
    Lehmann, LE
    Whyte, EA
    Russell, JD
    Spencer, S
    McIntosh, K
    Guinan, EC
    BLOOD, 1999, 94 (10) : 340A - 340A
  • [37] Comparative Evaluation of Three Automated Systems for DNA Extraction in Conjunction with Three Commercially Available Real-Time PCR Assays for Quantitation of Plasma Cytomegalovirus DNAemia in Allogeneic Stem Cell Transplant Recipients
    Bravo, Dayana
    Angeles Clari, Maria
    Costa, Elisa
    Munoz-Cobo, Beatriz
    Solano, Carlos
    Jose Remigia, Maria
    Navarro, David
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (08) : 2899 - 2904
  • [38] A real-time TaqMan PCR for routine quantitation of cytomegalovirus DNA in crude leukocyte lysates from stem cell transplant patients
    Yun, ZB
    Lewensohn-Fuchs, I
    Ljungman, P
    Ringholm, L
    Jonsson, J
    Alberta, J
    JOURNAL OF VIROLOGICAL METHODS, 2003, 110 (01) : 73 - 79
  • [39] CHIMERISM ANALYSIS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: QUANTITATIVE REAL-TIME OR SHORT TANDEM REPEAT PCR?
    Lukanov, Tsvetelin
    Ivanova-Shivarova, Milena
    Naumova, Elissaveta
    COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES, 2015, 68 (04): : 521 - 528
  • [40] Early detection of plasma cytomegalovirus DNA by real-time PCR after allogeneic hematopoietic stem cell transplantation
    Onishi, Yasushi
    Mori, Shin-Ichiro
    Higuchi, Akiko
    Kim, Sung-Won
    Fukuda, Takahiro
    Heike, Yuji
    Tanosaki, Ryuji
    Minematsu, Toshio
    Takaue, Yoichi
    Sasaki, Takeshi
    Furuta, Koh
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 210 (02): : 125 - 135
12345